Glycosmicine → (2r)-t-Butoxycarbonylamino-5-(1,2,3,4-tetrahydro-1-methyl-2,4-dioxoquinazolin-3-yl)pentanoic acid t-butyl ester

HRID 651339

반응식

HRID 651339 반응식
[H-].[Na+].[CH3:3][N:4]1[C:13]2[C:8](=[CH:9][CH:10]=[CH:11][CH:12]=2)[C:7](=[O:14])[NH:6][C:5]1=[O:15].[C:16]([O:20][C:21](=[O:35])[C@H:22]([NH:27][C:28]([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])=[O:29])[CH2:23][CH2:24][CH2:25]I)([CH3:19])([CH3:18])[CH3:17]>CN(C=O)C.C1OCCOCCOCCOCCOCCOC1>[C:16]([O:20][C:21](=[O:35])[C@H:22]([NH:27][C:28]([O:30][C:31]([CH3:34])([CH3:33])[CH3:32])=[O:29])[CH2:23][CH2:24][CH2:25][N:6]1[C:7](=[O:14])[C:8]2[C:13](=[CH:12][CH:11]=[CH:10][CH:9]=2)[N:4]([CH3:3])[C:5]1=[O:15])([CH3:17])([CH3:18])[CH3:19]

참가 물질

6

반응물 3

HCID 11788GlycosmicineHCID 24758Sodium hydrideHCID 15479355N-Boc-5-Iodo-D-norvaline tert-butyl ester

생성물 1

HCID 69288498(2r)-t-Butoxycarbonylamino-5-(1,2,3,4-tetrahydro-1-methyl-2,4-dioxoquinazolin-3-yl)pentanoic acid t-butyl ester수율 95%

시약·촉매·용매 2

HCID 2855718-Crown-6촉매HCID 6228Dimethylformamide용매2회

실험 절차

Sodium hydride (0.408 g, 10.2 mmol) was added to a solution of 1,2,3,4-tetrahydro-1-methyl-2,4-dioxoquinazoline (2.17 g, 12.4 mmol) and 18-crown-6 (0.045 g) in 25 mL of DMF. After stirring at RT for 30 min, (2R)-(t-butyloxycarbonylamino)-5-iodopentanoic acid t-butyl ester (3.60 g, 9.02 mmol) in 15 mL of DMF was added, and the solution was stirred at RT for 30 min, then at 60° C. for 6 h. The solvent was removed under reduced pressure, and the residue was partitioned between ethyl acetate and 0.05M aqueous HCl. The organic phase was washed with water and brine, dried over MgSO4 and concentrated. The crude material was purified by silica gel chromatography (hexane/ethyl acetate 3/1˜2/1) to give the title compound (3.81 g, 95% yield): NMR (400 MHz, CDCl3) 1.42 (s, 9H), 1.45 (s, 9H), 1.60-1.88 (m, 4H), 3.60 (s, 3H), 4.08-4.21 (m, 3H), 5.06 (br d, 1H, J=8.1 Hz), 7.19-7.31 (m, 2H), 7.68 (dt, 1H, J=7.84, 1.56 Hz), 8.22 (dd, 1H, J=7.88, 1.52 Hz).

후처리

  1. stirringthe solution was stirred at RT for 30 min
  2. waitat 60° C. for 6 h
  3. customThe solvent was removed under reduced pressure
  4. customthe residue was partitioned between ethyl acetate and 0.05M aqueous HCl
  5. washThe organic phase was washed with water and brine
  6. dry with materialdried over MgSO4
  7. concentrationconcentrated
  8. customThe crude material was purified by silica gel chromatography (hexane/ethyl acetate 3/1˜2/1)

출처 및 근거

ORD 기록
ord-a47daa744a794d46a8a7db35e54db661
출처 데이터셋
uspto-grants-2001_08
특허 번호
US06277987B1

연결된 노트

불러오는 중…